Inventor
LAJINESS JAMES PAUL
US14 patents
⚠️ This page may combine multiple inventors who share the name “LAJINESS JAMES PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
13 patentsUS11091499B2Aug 17, 2021
Compounds and compositions for inducing chondrogenesis
NOVARTIS AG5 citations83
US10660881B2May 26, 2020
Compounds and compositions for inducing chondrogenesis
NOVARTIS AG3 citations83
US10188638B2Jan 29, 2019
Compounds and compositions for inducing chondrogenesis
NOVARTIS AG4 citations83
US11753416B2Sep 12, 2023
Compounds and compositions for inducing chondrogenesis
NOVARTIS AG4 citations74
US11510912B2Nov 29, 2022
Compounds and compositions for inducing chondrogenesis
NOVARTIS AG2 citations72
US10383863B2Aug 20, 2019
Compounds and compositions for inducing chondrogenesis
NOVARTIS AG2 citations72
US12280041B2Apr 22, 2025
Compounds and compositions for inducing chondrogenesis
NOVARTIS AG0 citations62
US12209096B2Jan 28, 2025
Compounds and compositions for inducing chondrogenesis
NOVARTIS AG0 citations62
US11203595B2Dec 21, 2021
Aza-indazole compounds for use in tendon and/or ligament injuries
NOVARTIS AG0 citations58
US10766894B2Sep 8, 2020
Aza-indazole compounds for use in tendon and/or ligament injuries
NOVARTIS AG1 citations58
US12365692B2Jul 22, 2025
6-hydroxy-8-oxatricyclo[3.2.1.02,4]octane-2-carboxamide derivatives for inducing chondrogenesis for treating joint damage
NOVARTIS AG0 citations53
US10112907B2Oct 30, 2018
Substituted indazoles for treating tendon and/or ligament injuries
NOVARTIS AG1 citations48
US12257243B2Mar 25, 2025
5-hydroxy-7-oxabicyclo[2.2.1]heptane-2-carboxamide derivatives for inducing chondrogenesis for treating joint damage
NOVARTIS AG0 citations42